Table 1 Primary antibodies and conditions used for immunohistological studies
Marker | Clone | Dilution | Antigen retrieval | Source | Interpretation (positive) |
|---|---|---|---|---|---|
CD45RB | PD7/26+2B11 | 1:500 | MW; CB | Dako | >50% |
CD20 | L26 | 1:1200 | MW; CB | Dako | >50% |
CD3 | SP7 | 1:200 | S; CB | Lab Vision | >50% |
CD30 | BerH2 | 1:900 | S; CB | Dako | >50% |
CD15 | Leu M1 | 1:50 | MW; CB | BD | Any |
LMP-1 | CS1-4 | 1:200 | S; CB | Dako | >10% |
CD79a | 124 | 1:400 | MW; CB | Dako | >50% |
BCL-6 | PG-B6P | 1:100 | T+S; TRIS | Dako | >50% |
P63 | 4A4 | 1:250 | PC; CB | Lab Vision | >50% |
BOB-1 | BOB1 | 1:80 | PC; CB | Novocastra | >30% |
Ki-67 | MIB-1 | 1:4800 | PC; CB | Dako | % |
BCL-2 | 124 | 1:400 | MW; CB | Dako | >30% |
IRF4/MUM-1 | MUM1P | 1:1200 | S; CB | Dako | >30% |
PAX5 | DAK-PAX5 | 1:400 | S; CB | Dako | >50% |
OCT2 | OCT-2 | 1:500 | MW; EDTA | Sta. Cruz | >30% |
CD23 | SP23 | 1:400 | MW; CB | Lab Vision | >25% |
